Abstract
Introduction
Premedication is the preoperative nasal, oral, rectal, intramuscular or intravenous administration of sedative drugs to lower the patient's fear of surgical intervention, achieve sedation and anxiolysis, and decrease the amount of anesthetics needed. 1 ---6 In addition to benzodiazepines such as midazolam, which are commonly used for this purpose, the use of alpha 2 agonists such as clonidine and dexmedetomidine is becoming popular. 3 ---8 For pediatric patients, it is essential that premedication agents are administered noninvasively, i.e., transmucosally, nasally or orally. 3---5,7,8 Rectal administration is also preferred, particularly for the premedication of young children. 2,3,9---11 Previous studies have shown that, similar to midazolam and ketamine, clonidine can be administered rectally for premedication. 2,9---14 Dexmedetomidine is an alpha adrenergic agonist with high levels of specificity and selectivity to alpha 2 receptors. Dexmedetomidine can be used for sedation, analgesia and anesthesia in intensive care settings, as well as for local and regional anesthesia applications. 8,15---17 Research has also shown that dexmedetomidine can be administered orally, nasally, transmucosally or intramuscularly for premedication. 4,8,18---24 However, there are no published studies concerning the rectal application of dexmedetomidine for premedication.
Our hypothesis was that dexmedetomidine administered rectally to rats would produce a sedative effect with no damage to the rectal mucosa.
To test this hypothesis, we compared the anesthetic effects of equal doses of dexmedetomidine administered rectally or intraperitoneally to rats. In addition, we compared the histopathological effects on rectal mucosa of rectally administered dexmedetomidine.
Materials and methods
This study was approved by the Animal Ethics Committee of the Bulent Ecevit University (formerly Zonguldak Karaelmas University) Medical School. All the animals were treated humanely and in compliance with the recommendations of Este é um artigo Open Access sob a licença de CC BY-NC-ND Este é um artigo Open Access sob a licença de CC BY-NC-ND the university's animal care committee and the principles of laboratory animal care (NIH publication no. 85-23, revised in 1985) . The rats were housed in a temperature-controlled room (24 ± 1
• C) on a 12-h light---12-h dark cycle, and they were fed standard rat chow and water until 12 h before the experimental protocol.
Thirty-two male Wistar albino rats weighing between 250 and 300 g were randomly divided into four groups of eight rats. Group S (n = 8) was a sham group served as a baseline for the normal basal values; Group C (n = 8) consisted of rats that received the rectal application of saline alone; Group IPDex (n = 8) included rats that received the intraperitoneal application of dexmedetomidine; and Group RecDex (n = 8) included rats that received the rectal application of dexmedetomidine.
The rats' weights were measured prior to the experiment. For rectal drug administration, we used 22 G intravenous cannulas with the stylets removed. We administered the drugs by advancing the cannula 1 cm into the rectum, and the rectal administration volume was 1 mL for all the rats. 25 We identified the onset and duration of anesthesia in all the groups by observing the righting reflex. 26 We measured the latency of anesthesia (the time required to lose the righting reflex) and the anesthesia time (the duration of the loss of the righting reflex) in minutes (min). 26 Tw o hours after rectal study drug's administration; 75 mg kg −1 ketamine was used in all the groups for intraperitoneal anesthesia, followed by the removal of the rats' rectums to a distal distance of 3 cm via an abdominoperineal surgical procedure. 25 We histopathologically examined and scored the rectums.
27

Preliminary study
Before the experiment, we evaluated the effectiveness of different doses of rectally administered dexmedetomidine from previous studies. 16, 17, 28 We administered 1 g kg −1 , 10 g kg −1 , 50 g kg −1 and 100 g kg −1 dexmedetomidine rectally to the two rats in each group. 25 In the preliminary study, anesthesia was not achieved with the rectal administration of 1 or 10 g kg −1 dexmedetomidine; however, anesthesia was obtained in one of the rats that received 50 g kg −1 dexmedetomidine rectally and in both rats that received 100 g kg −1 dexmedetomidine rectally. Therefore, 100 g kg −1 was chosen as the dose of dexmedetomidine to be used rectally and intraperitoneally.
Groups
The rats in the sham group (n = 8) did not receive the rectal administration of any substances. These rats were used as controls for the histopathological examination of the rectum. They were administered 75 mg kg −1 i.p. ketamine, followed by the removal of the rectum to a distal distance of 3 cm via abdominoperineal surgery. 25 We examined the rats' rectums and scored them histopathologically. 27 The rats in the control group (n = 8) received 1 mL of saline by the advancement of a 22 G intravenous cannula with no stylet 1 cm into the rectum. After the saline administration, we measured the anesthesia duration in the rats. 26 We removed their rectums to a distal distance of 3 cm via abdominoperineal surgery. 26 We examined the rectums and scored them histopathologically. 27 We administered 100 g kg
dexmedetomidine intraperitoneally to the rats in group IPDex (intraperitoneal dexmedetomidine group, n = 8). We established the proper dosage of dexmedetomidine with the help of the preliminary study and previous research. 16, 17, 28 After the administration of dexmedetomidine, we measured the anesthesia duration in the rats. 26 In the rectal dexmedetomidine group (Group RecDex, n = 8), saline was added to 100 g kg −1 dexmedetomidine to a total volume of 1 mL and was administered rectally by advancing a 22 G intravenous cannula with no stylet 1 cm into the rectum. After administering the dexmedetomidine, we measured the anesthesia duration in the rats. 26 The rectums of the rats were removed to a distal distance of 3 cm via abdominoperineal surgery. 25 The rectums were examined histopathologically and scored. 27 
Histologic assessment of colonic mucosal damage
For the light microscopic observation, distal colon specimens were embedded in paraffin blocks after being fixed in a 10% formalin solution. Five-micrometer (5-m) sections were obtained and stained with hematoxylin---eosin and Masson's trichrome using standard methods. A histologist graded the colonic pathological changes in a blinded manner using the histologic injury scale previously developed by Leung et al. 27 Briefly, mucosal damage was graded from 0 to 4 according to the following criteria: grade 0, normal mucosa; grade 1, damage to the surface epithelium only; grade 2, damage to the epithelium of the upper half of the gland; grade 3, damage to the majority of the glandular epithelium that did not extend to the base of the gland; and grade 4, the destruction of the epithelium of the entire gland.
Statistical analysis
We performed the statistical analysis was using the Statistical Package for the Social Sciences (SPSS) version 16.0 for Windows (SPSS, Chicago, IL). For the scores and nonnormally distributed variables, we compared the groups using the Mann---Whitney U and Kruskal---Wallis tests. The results were expressed as medians (25th---75th percentiles). A p value < 0.05 was considered statistically significant.
Results
Results concerning the duration of anesthesia and the rectal histopathological evaluations were obtained.
Duration of anesthesia
We achieved anesthesia in all the rats in the intraperitoneal and rectal dexmedetomidine groups following the administration of dexmedetomidine (p < 0.001). In both of these groups, the duration of anesthesia was significantly longer than in the sham and control groups (p < 0.001). In the Group IPDex, the onset of anesthesia occurred significantly more rapidly than in the Group RecDex (p < 0.001). In contrast, the duration of anesthesia in the Group IPDex was significantly longer than in the Group RecDex (p < 0.001) ( Table 1) .
Histopathological findings
The histologic features of the colonic and rectal walls of the Sham and Control groups were determined to be normal (Fig. 1A---D) . In the Group RecDex, the drug induced mild and moderate losses of the mucosal architecture in the colon and rectum, 2 h after rectal inoculation (Fig. 1E---F) . The histological examinations demonstrated the presence of mucosal damage with the loss of surface and glandular epithelial cells. As shown in Table 1 , the microscopic score (2 [2-2]) of the colons from the Group RecDex was significantly higher than that of the colon and rectum segments from the sham and control rats (p < 0.001) ( Table 2 ).
Discussion
In this study, rectal dexmedetomidine administration was shown to have anesthetic activity but to also cause significant mucosal damage to rat rectal mucosa compared with the sham and control groups. Alpha 2 agonists constitute a group of drugs commonly used in anesthesia for the purposes of sedation, analgesia and anesthesia.
11---14,18---24 Clonidine, a member of this group, can also be used for premedication.
11---14 Rectal premedication administration is particularly preferred for young children due to the ease of administration.
2,3,9---11
Previous studies have reported that clonidine can be used effectively rectally. 11---14 Comparing the effectiveness of rectally administered clonidine to that of midazolam, Bergendahl et al. 11 found that the use of the former as premedication resulted in lower pain scores than midazolam in the early postoperative stage. The authors also reported that children who were rectally administered ketamine were more sedated in first 24 postoperative hours than those who received midazolam. 11 In a study comparing the rectal administration of 2.5 g kg −1 clonidine and 300 g kg
midazolam to prevent the increase in neuropeptide Y caused by tracheal intubation in children, Bergendal et al. 13 concluded that there was no significant difference between the two groups. A study that investigated the pharmacokinetic characteristics of rectally administered clonidine demonstrated that its maximum plasma concentration was 0.77 ng mL −1 and that the time required to reach this concentration was 51 min. 14 The same study found that the half-life of rectal clonidine was 12.5 h and the bioavailability was 95%. The authors reported that the plasma concentration of clonidine reached clinically effective levels 10 min after rectal administration.
14 They stated that 2.5 g kg
clonidine rectally administered to children approximately 20 min before anesthesia induction could achieve a clinically effective plasma concentration.
14 Dexmedetomidine is a highly specific and sensitive alpha adrenergic agonist, and it can be administered orally, nasally, transmucosally or intramuscularly for premedication.
4,8,18---24
Özcengiz et al. 20 showed that oral dexmedetomidine could prevent post-sevolurane agitation in children. Yuen et al. 4 reported that 1 g kg −1 intranasal dexmedetomidine produced significantly higher sedation in children aged 2---12 years compared with oral midazolam. The authors emphasized that dexmedetomidine and midazolam created similar premedication conditions and that both were acceptable. 4 In another study, Yuen et al. 29 found that sedation began an average of 25 min after intranasal dexmedetomidine and that the mean duration of sedation was 85 min. Sakurai et al. 21 reported that 3 ---4 g kg −1 dexmedetomidine administered to children buccally 1 h before surgery was reliable and effective.
In a comparison of the effects of 2 g kg −1 intranasal dexmedetomidine and 0.5 mg kg −1 midazolam for premedication in pediatric patients, Talon et al. 22 found that the two drugs had similar anesthesia induction and recovery characteristics. However, the authors reported that dexmedetomidine was more effective in inducing sleep and that it was a useful alternative to oral midazolam. 22 Although the rectal use of clonidine and the oral, nasal and transmucosal use of dexmedetomidine for premedication have been defined, there is no literature on the rectal use of dexmedetomidine.
In our study, the rectal administration of 100 g kg
dexmedetomidine achieved anesthesia in all the rats in that group. The duration of anesthesia in both the groups that received intraperitoneal and rectal dexmedetomidine was significantly longer than in the sham and control groups. However, the onset of anesthesia was significantly later in the rectal dexmedetomidine group than in the intraperitoneal dexmedetomidine group, and the duration of anesthesia was significantly shorter than in the intraperitoneal group. Rectal administration is an alternative method of premedication, particularly for young children. The absorption mechanisms of rectally administered drugs resemble the upper gastrointestinal system. Passive transport is the main mechanism of rectal drug absorption. The absorption speed of rectally administered drugs is influenced by factors such as the molecular weight, lipid solubility and ionization degree of the drug. However, the rectal administration of drugs has been reported to cause side effects such as local inflammation, rectal mucosal damage, rectal ulceration, rectal bleeding and pain. 30 The rectal administration of anesthetic agents may also cause rectal mucosal damage. 25 Previous studies have shown that rectally administered 10% methohexitone causes rectal mucosal damage in rats that begins within minutes, becomes noticeable at 60 min, and continues 24 h. 25 However, there have been only a few studies of the rectal mucosal effects of alpha 2 agonists. 31, 32 Maxson et al. 31 reported clonidine administration to rats to decrease mucus production in an intestinal ischemia/reperfusion model. In a case study, the long-term use of clonidine was reported to cause cicatricial pemphigoid in the anus, vulva mucosa and perianal skin. 32 In that case, the direct immunoflourescent examination of the lesions indicated the possibility of complement-mediated tissue damage between epidermal basal cells and the basal membrane. 32 In our literature review, we were not able to find a study that evaluated the effects of rectally administered clonidine on rectal mucosa cells. We found in our study that rectally administered 100 g kg −1 dexmedetomidine caused the moderate loss of the rectal mucosal surface and glandular epithelial cells. We are of the opinion that the mucosal damage caused by dexmedetomidine may have a mechanism similar to that of clonidine. 31, 32 However, we did not investigate the mechanisms of mucosal damage formation in the present study. These preliminary findings in rats may not be observed in rectal mucosa of humans due to the high dose and resulting high concentration applied to the rectal mucosa in this study. We believe that future studies should investigate the effects of dexmedetomidine on rectal mucosa and the reversibility of the damage.
The dexmedetomidine dosage used in our study was identified as the most effective in rectal use in the preliminary study. Several other studies have demonstrated neuroprotective effects of dexmedetomidine, albeit only at higher doses (up to 100 g kg −1 ).
33---35
In conclusion, although the rectal administration of dexmedetomidine to rats achieved a significantly longer duration of anesthesia compared with saline, our histopathological evaluation showed that the former treatment led to moderate damage in the mucosal structure of the rectum. Therefore, for the rectally safe use of dexmedetomidine as premedication, we believe that future studies are needed to reveal the effects of the drug on rectal mucosa.
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